Page URL: https://www.bionews.org.uk/page_136791

Repetitive behaviours in rare form of autism 'edited out' in mice

2 July 2018
Appeared in BioNews 956

Genome editing technology has been used to edit out autistic traits in mice with a rare form of the condition, according to a new study in the journal Nature Biomedical Engineering

A neurotransmitter receptor gene called mGluR5 was edited, which reduced the repetitive behaviour of mice with fragile X syndrome. This condition affects about 2 percent of people who have autism. 

The scientists injected gold nanoparticles to deliver the CRISPR/Cas9 system to mice's brains. This meant that the researchers could precisely control how much of the Cas9 protein – which cuts the DNA – was delivered. 

This approach halved levels of the mGluR5 protein in the mice and significantly reduced repetitive behaviours associated with autism spectrum disorder. It resulted in a 30 percent reduction in repetitive digging and a 70 percent decrease in leaping. Using the 'CRISPR-gold' method (see BioNews 921) also avoids problems with viral delivery systems, which can have higher toxicity and trigger an immune response. 

'There are no treatments or cures for autism yet, and many of the clinical trials of small-molecule treatments targeting proteins that cause autism have failed,' said study leader Dr Hye Young Lee, an assistant professor of cellular and integrative physiology at the University of Texas Health Science Center at San Antonio. 'This is the first case where we were able to edit a causal gene for autism in the brain and show rescue of the behavioural symptoms.' 

Fragile X syndrome is caused by a single-gene mutation. In most cases, autism spectrum disorder is a complex developmental condition, with both genetic and environmental influences. In many cases, there are multiple genes that play a role in the condition. In total, there are around 700,000 people with autism in the UK. 

The lab is currently working on a way of delivering the nanoparticles via an injection into the spinal cord rather than through the skull into the brain. At the moment, however, much more work is needed before the trials progress to humans. The authors hope that the same approach could also be used to treat other diseases caused by a known single gene. 

SOURCES & REFERENCES
Autism traits could be 'edited' out genetic trial suggests
The Telegraph |  25 June 2018
CRISPR reduces autism symptoms in mice
University of California, Berkeley |  25 June 2018
Editing Autism Gene with Nano-CRISPR Curbs Repetitive Behaviors
Genetic Engineering & Biotechnology News |  27 June 2018
Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours
Nature Biomedical Engineering |  25 June 2018
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
25 June 2018 - by Grace O'Regan 
A common genetic basis has been found for schizophrenia, major depression, attention deficit hyperactivity disorder (ADHD) and bipolar disorder, a new study has found this week...
4 June 2018 - by Ewa Zotow 
Scientists have found a set of genes that may explain the unusually large size of the human brain in comparison with other apes...
4 December 2017 - by Dr Kristien Hens and Dr Leni Van Goidsenhoven 
Popular scientific publications regularly have articles with headlines suggesting that 'autism is hereditary' or that the 'risk for developing autism' is mostly caused by genetics...
9 October 2017 - by Emma Laycock 
Scientists have repaired the faulty gene in a mouse model of muscular dystrophy by using gold nanoparticles to deliver the genome editing tool CRISPR-Cas9...
2 October 2017 - by Shaoni Bhattacharya 
Genetic factors may explain most of the risk of developing autism spectrum disorder (ASD), suggests a new analysis...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.